{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-cancer", "apoptosis", "diosgenin", "metastasis", "oncogenic", "steroidal sapogenins"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29783752", "DateCompleted": {"Year": "2018", "Month": "10", "Day": "09"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "05", "Day": "19"}], "Language": ["eng"], "ELocationID": ["645", "10.3390/nu10050645"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "10", "Issue": "5", "PubDate": {"Year": "2018", "Month": "May", "Day": "19"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review.", "Abstract": {"AbstractText": ["Novel and alternative options are being adopted to combat the initiation and progression of human cancers. One of the approaches is the use of molecules isolated from traditional medicinal herbs, edible dietary plants and seeds that play a pivotal role in the prevention/treatment of cancer, either alone or in combination with existing chemotherapeutic agents. Compounds that modulate these oncogenic processes are potential candidates for cancer therapy and may eventually make it to clinical applications. Diosgenin is a naturally occurring steroidal sapogenin and is one of the major bioactive compounds found in dietary fenugreek (<i>Trigonella foenum-graecum</i>) seeds. In addition to being a lactation aid, diosgenin has been shown to be hypocholesterolemic, gastro- and hepato-protective, anti-oxidant, anti-inflammatory, anti-diabetic, and anti-cancer. Diosgenin has a unique structural similarity to estrogen. Several preclinical studies have reported on the pro-apoptotic and anti-cancer properties of diosgenin against a variety of cancers, both in in vitro and in vivo. Diosgenin has also been reported to reverse multi-drug resistance in cancer cells and sensitize cancer cells to standard chemotherapy. Remarkably, diosgenin has also been reported to be used by pharmaceutical companies to synthesize steroidal drugs. Several novel diosgenin analogs and nano-formulations have been synthesized with improved anti-cancer efficacy and pharmacokinetic profile. In this review we discuss in detail the multifaceted anti-cancer properties of diosgenin that have found application in pharmaceutical, functional food, and cosmetic industries; and the various intracellular molecular targets modulated by diosgenin that abrogate the oncogenic process."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department for Management of Science and Technology Development, Ton Duc Thang University, Ho Chi Minh City 700000, Vietnam. gautam.sethi@tdt.edu.vn."}, {"Identifier": [], "Affiliation": "Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 700000, Vietnam. gautam.sethi@tdt.edu.vn."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore. phcgs@nus.edu.sg."}], "LastName": "Sethi", "ForeName": "Gautam", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore. phcsmk@nus.edu.sg."}], "LastName": "Shanmugam", "ForeName": "Muthu K", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Stem Cells and Cardiovascular Regeneration, Manipal Institute of Regenerative Medicine, Manipal University, Bangalore 560065, India. sudha.warrier@manipal.edu."}], "LastName": "Warrier", "ForeName": "Sudha", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore. myriammerarchi@hotmail.fr."}], "LastName": "Merarchi", "ForeName": "Myriam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cell and Cancer Biology Laboratory, School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, WA 6102, Australia. frank.arfuso@curtin.edu.au."}], "LastName": "Arfuso", "ForeName": "Frank", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore. phcapk@nus.edu.sg."}], "LastName": "Kumar", "ForeName": "Alan Prem", "Initials": "AP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Larkin University, 18301 N. Miami Avenue, Miami, FL 33169, USA. abishayee@ularkin.org"}], "LastName": "Bishayee", "ForeName": "Anupam", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Apoptosis Regulatory Proteins"}, {"RegistryNumber": "K49P2K8WLX", "NameOfSubstance": "Diosgenin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Apoptosis Regulatory Proteins"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Diosgenin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}], "CoiStatement": "The authors declare no conflict of interest. "}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2017. CA Cancer J. Clin. 2017;67:7\u201330. doi: 10.3322/caac.21387.", "ArticleIdList": ["10.3322/caac.21387", "28055103"]}, {"Citation": "Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 2000;100:57\u201370. doi: 10.1016/S0092-8674(00)81683-9.", "ArticleIdList": ["10.1016/S0092-8674(00)81683-9", "10647931"]}, {"Citation": "Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646\u2013674. doi: 10.1016/j.cell.2011.02.013.", "ArticleIdList": ["10.1016/j.cell.2011.02.013", "21376230"]}, {"Citation": "Hanahan D. Rethinking the war on cancer. Lancet. 2014;383:558\u2013563. doi: 10.1016/S0140-6736(13)62226-6.", "ArticleIdList": ["10.1016/S0140-6736(13)62226-6", "24351321"]}, {"Citation": "Floor S.L., Dumont J.E., Maenhaut C., Raspe E. Hallmarks of cancer: Of all cancer cells, all the time? Trends Mol. Med. 2012;18:509\u2013515. doi: 10.1016/j.molmed.2012.06.005.", "ArticleIdList": ["10.1016/j.molmed.2012.06.005", "22795735"]}, {"Citation": "Pietras K., Ostman A. Hallmarks of cancer: Interactions with the tumor stroma. Exp. Cell Res. 2010;316:1324\u20131331. doi: 10.1016/j.yexcr.2010.02.045.", "ArticleIdList": ["10.1016/j.yexcr.2010.02.045", "20211171"]}, {"Citation": "Massague J., Obenauf A.C. Metastatic colonization by circulating tumour cells. Nature. 2016;529:298\u2013306. doi: 10.1038/nature17038.", "ArticleIdList": ["10.1038/nature17038", "PMC5029466", "26791720"]}, {"Citation": "Chaffer C.L., Weinberg R.A. How does multistep tumorigenesis really proceed? Cancer Discov. 2015;5:22\u201324. doi: 10.1158/2159-8290.CD-14-0788.", "ArticleIdList": ["10.1158/2159-8290.CD-14-0788", "PMC4295623", "25583800"]}, {"Citation": "Iwatsuki M., Mimori K., Yokobori T., Ishi H., Beppu T., Nakamori S., Baba H., Mori M. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010;101:293\u2013299. doi: 10.1111/j.1349-7006.2009.01419.x.", "ArticleIdList": ["10.1111/j.1349-7006.2009.01419.x", "19961486"]}, {"Citation": "Almendro V., Marusyk A., Polyak K. Cellular heterogeneity and molecular evolution in cancer. Annu. Rev. Pathol. 2013;8:277\u2013302. doi: 10.1146/annurev-pathol-020712-163923.", "ArticleIdList": ["10.1146/annurev-pathol-020712-163923", "23092187"]}, {"Citation": "Steeg P.S. Targeting metastasis. Nat. Rev. Cancer. 2016;16:201\u2013218. doi: 10.1038/nrc.2016.25.", "ArticleIdList": ["10.1038/nrc.2016.25", "PMC7055530", "27009393"]}, {"Citation": "Wang Z., Dabrosin C., Yin X., Fuster M.M., Arreola A., Rathmell W.K., Generali D., Nagaraju G.P., El-Rayes B., Ribatti D., et al. Broad targeting of angiogenesis for cancer prevention and therapy. Semin. Cancer Biol. 2015;35:S224\u2013S243. doi: 10.1016/j.semcancer.2015.01.001.", "ArticleIdList": ["10.1016/j.semcancer.2015.01.001", "PMC4737670", "25600295"]}, {"Citation": "Sethi G., Ahn K.S., Aggarwal B.B. Targeting nuclear factor-kappa B activation pathway by thymoquinone: Role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol. Cancer Res. 2008;6:1059\u20131070. doi: 10.1158/1541-7786.MCR-07-2088.", "ArticleIdList": ["10.1158/1541-7786.MCR-07-2088", "18567808"]}, {"Citation": "Tang C.H., Sethi G., Kuo P.L. Novel medicines and strategies in cancer treatment and prevention. BioMed Res. Int. 2014;2014:474078. doi: 10.1155/2014/474078.", "ArticleIdList": ["10.1155/2014/474078", "PMC4058237", "24971330"]}, {"Citation": "Ahn K.S., Sethi G., Aggarwal B.B. Nuclear factor-kappa B: From clone to clinic. Curr. Mol. Med. 2007;7:619\u2013637. doi: 10.2174/156652407782564363.", "ArticleIdList": ["10.2174/156652407782564363", "18045141"]}, {"Citation": "Chai E.Z., Shanmugam M.K., Arfuso F., Dharmarajan A., Wang C., Kumar A.P., Samy R.P., Lim L.H., Wang L., Goh B.C., et al. Targeting transcription factor stat3 for cancer prevention and therapy. Pharmacol. Ther. 2016;162:86\u201397. doi: 10.1016/j.pharmthera.2015.10.004.", "ArticleIdList": ["10.1016/j.pharmthera.2015.10.004", "26478441"]}, {"Citation": "Li F., Zhang J., Arfuso F., Chinnathambi A., Zayed M.E., Alharbi S.A., Kumar A.P., Ahn K.S., Sethi G. NF-kappaB in cancer therapy. Arch. Toxicol. 2015;89:711\u2013731. doi: 10.1007/s00204-015-1470-4.", "ArticleIdList": ["10.1007/s00204-015-1470-4", "25690730"]}, {"Citation": "Shanmugam M.K., Kannaiyan R., Sethi G. Targeting cell signaling and apoptotic pathways by dietary agents: Role in the prevention and treatment of cancer. Nutr. Cancer. 2011;63:161\u2013173. doi: 10.1080/01635581.2011.523502.", "ArticleIdList": ["10.1080/01635581.2011.523502", "21294053"]}, {"Citation": "Deorukhkar A., Krishnan S., Sethi G., Aggarwal B.B. Back to basics: How natural products can provide the basis for new therapeutics. Expert Opin. Investig. Drugs. 2007;16:1753\u20131773. doi: 10.1517/13543784.16.11.1753.", "ArticleIdList": ["10.1517/13543784.16.11.1753", "17970636"]}, {"Citation": "Kneller R. The importance of new companies for drug discovery: Origins of a decade of new drugs. Nat. Rev. Drug Discov. 2010;9:867\u2013882. doi: 10.1038/nrd3251.", "ArticleIdList": ["10.1038/nrd3251", "21031002"]}, {"Citation": "Bishayee A., Sethi G. Bioactive natural products in cancer prevention and therapy: Progress and promise. Semin. Cancer Biol. 2016;40\u201341:1\u20133. doi: 10.1016/j.semcancer.2016.08.006.", "ArticleIdList": ["10.1016/j.semcancer.2016.08.006", "27565447"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Newman D.J. Developing natural product drugs: Supply problems and how they have been overcome. Pharmacol. Ther. 2016;162:1\u20139. doi: 10.1016/j.pharmthera.2015.12.002.", "ArticleIdList": ["10.1016/j.pharmthera.2015.12.002", "26706239"]}, {"Citation": "Newman D.J. Bioactive cyclic molecules and drug design. Expert Opin. Drug Discov. 2018;13:379\u2013385. doi: 10.1080/17460441.2018.1445085.", "ArticleIdList": ["10.1080/17460441.2018.1445085", "29513042"]}, {"Citation": "Shanmugam M.K., Lee J.H., Chai E.Z., Kanchi M.M., Kar S., Arfuso F., Dharmarajan A., Kumar A.P., Ramar P.S., Looi C.Y., et al. Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds. Semin. Cancer Biol. 2016;40\u201341:35\u201347. doi: 10.1016/j.semcancer.2016.03.005.", "ArticleIdList": ["10.1016/j.semcancer.2016.03.005", "27038646"]}, {"Citation": "Shanmugam M.K., Nguyen A.H., Kumar A.P., Tan B.K., Sethi G. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer. Cancer Lett. 2012;320:158\u2013170. doi: 10.1016/j.canlet.2012.02.037.", "ArticleIdList": ["10.1016/j.canlet.2012.02.037", "22406826"]}, {"Citation": "Shanmugam M.K., Warrier S., Kumar A.P., Sethi G., Arfuso F. Potential role of natural compounds as anti-angiogenic agents in cancer. Curr. Vasc. Pharmacol. 2017;15:503\u2013519. doi: 10.2174/1570161115666170713094319.", "ArticleIdList": ["10.2174/1570161115666170713094319", "28707601"]}, {"Citation": "Mishra K.P., Ganju L., Sairam M., Banerjee P.K., Sawhney R.C. A review of high throughput technology for the screening of natural products. Biomed. Pharmacother. 2008;62:94\u201398. doi: 10.1016/j.biopha.2007.06.012.", "ArticleIdList": ["10.1016/j.biopha.2007.06.012", "17692498"]}, {"Citation": "Cragg G.M., Grothaus P.G., Newman D.J. Impact of natural products on developing new anti-cancer agents. Chem. Rev. 2009;109:3012\u20133043. doi: 10.1021/cr900019j.", "ArticleIdList": ["10.1021/cr900019j", "19422222"]}, {"Citation": "Harvey A.L., Edrada-Ebel R., Quinn R.J. The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 2015;14:111\u2013129. doi: 10.1038/nrd4510.", "ArticleIdList": ["10.1038/nrd4510", "25614221"]}, {"Citation": "Newman D.J. Natural products as leads to potential drugs: An old process or the new hope for drug discovery? J. Med. Chem. 2008;51:2589\u20132599. doi: 10.1021/jm0704090.", "ArticleIdList": ["10.1021/jm0704090", "18393402"]}, {"Citation": "Chai E.Z., Siveen K.S., Shanmugam M.K., Arfuso F., Sethi G. Analysis of the intricate relationship between chronic inflammation and cancer. Biochem. J. 2015;468:1\u201315. doi: 10.1042/BJ20141337.", "ArticleIdList": ["10.1042/BJ20141337", "25940732"]}, {"Citation": "Sung B., Prasad S., Yadav V.R., Aggarwal B.B. Cancer cell signaling pathways targeted by spice-derived nutraceuticals. Nutr. Cancer. 2012;64:173\u2013197. doi: 10.1080/01635581.2012.630551.", "ArticleIdList": ["10.1080/01635581.2012.630551", "PMC3645308", "22149093"]}, {"Citation": "Newman D.J., Cragg G.M. Current status of marine-derived compounds as warheads in anti-tumor drug candidates. Mar. Drugs. 2017;15:99. doi: 10.3390/md15040099.", "ArticleIdList": ["10.3390/md15040099", "PMC5408245", "28353637"]}, {"Citation": "Newman D.J., Cragg G.M. Drugs and drug candidates from marine sources: An assessment of the current \u201cstate of play\u201d. Planta Med. 2016;82:775\u2013789. doi: 10.1055/s-0042-101353.", "ArticleIdList": ["10.1055/s-0042-101353", "26891002"]}, {"Citation": "El Bairi K., Ouzir M., Agnieszka N., Khalki L. Anticancer potential of trigonella foenum graecum: Cellular and molecular targets. Biomed. Pharmacother. 2017;90:479\u2013491. doi: 10.1016/j.biopha.2017.03.071.", "ArticleIdList": ["10.1016/j.biopha.2017.03.071", "28391170"]}, {"Citation": "Shabbeer S., Sobolewski M., Anchoori R.K., Kachhap S., Hidalgo M., Jimeno A., Davidson N., Carducci M.A., Khan S.R. Fenugreek: A naturally occurring edible spice as an anticancer agent. Cancer Biol. Ther. 2009;8:272\u2013278. doi: 10.4161/cbt.8.3.7443.", "ArticleIdList": ["10.4161/cbt.8.3.7443", "PMC3095649", "19197146"]}, {"Citation": "Aggarwal B.B., Kunnumakkara A.B., Harikumar K.B., Tharakan S.T., Sung B., Anand P. Potential of spice-derived phytochemicals for cancer prevention. Planta Med. 2008;74:1560\u20131569. doi: 10.1055/s-2008-1074578.", "ArticleIdList": ["10.1055/s-2008-1074578", "18612945"]}, {"Citation": "Kenny O., Smyth T.J., Hewage C.M., Brunton N.P. Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of Fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit. Food Chem. 2013;141:4295\u20134302. doi: 10.1016/j.foodchem.2013.07.016.", "ArticleIdList": ["10.1016/j.foodchem.2013.07.016", "23993618"]}, {"Citation": "Wani S.A., Kumar P. Fenugreek: A review on its nutraceutical properties and utilization in various food products. J. Saudi Soc. Agric. Sci. 2018;17:97\u2013106. doi: 10.1016/j.jssas.2016.01.007.", "ArticleIdList": ["10.1016/j.jssas.2016.01.007"]}, {"Citation": "Kim J.K., Park S.U. An update on the biological and pharmacological activities of diosgenin. EXCLI J. 2018;17:24\u201328.", "ArticleIdList": ["PMC5780621", "29383016"]}, {"Citation": "Bahmani M., Shirzad H., Mirhosseini M., Mesripour A., Rafieian-Kopaei M. A review on ethnobotanical and therapeutic uses of Fenugreek (Trigonella foenum-graceum L.) J. Evid. Based Complement. Altern. Med. 2016;21:53\u201362. doi: 10.1177/2156587215583405.", "ArticleIdList": ["10.1177/2156587215583405", "25922446"]}, {"Citation": "Srinivasan K. Fenugreek (Trigonella foenum-graecum): A review of health beneficial physiological effects. Food Rev. Int. 2006;22:203\u2013224. doi: 10.1080/87559120600586315.", "ArticleIdList": ["10.1080/87559120600586315"]}, {"Citation": "Jesus M., Martins A.P., Gallardo E., Silvestre S. Diosgenin: Recent highlights on pharmacology and analytical methodology. J. Anal. Methods Chem. 2016;2016:4156293. doi: 10.1155/2016/4156293.", "ArticleIdList": ["10.1155/2016/4156293", "PMC5225340", "28116217"]}, {"Citation": "Yang S.F., Weng C.J., Sethi G., Hu D.N. Natural bioactives and phytochemicals serve in cancer treatment and prevention. Evid. Based Complement. Altern. Med. 2013;2013:698190. doi: 10.1155/2013/698190.", "ArticleIdList": ["10.1155/2013/698190", "PMC3880702", "24454507"]}, {"Citation": "Djerassi C., Rosenkranz G., Pataki J., Kaufmann S. Steroids, xxvii. Synthesis of allopregnane-3beta, 11beta, 17alpha-, 20beta, 21-pentol from cortisone and diosgenin. J. Biol. Chem. 1952;194:115\u2013118.", "ArticleIdList": ["14927598"]}, {"Citation": "Patel K., Gadewar M., Tahilyani V., Patel D.K. A review on pharmacological and analytical aspects of diosmetin: A concise report. Chin. J. Integr. Med. 2013;19:792\u2013800. doi: 10.1007/s11655-013-1595-3.", "ArticleIdList": ["10.1007/s11655-013-1595-3", "24092244"]}, {"Citation": "Chen Y., Tang Y.M., Yu S.L., Han Y.W., Kou J.P., Liu B.L., Yu B.Y. Advances in the pharmacological activities and mechanisms of diosgenin. Chin. J. Nat. Med. 2015;13:578\u2013587. doi: 10.1016/S1875-5364(15)30053-4.", "ArticleIdList": ["10.1016/S1875-5364(15)30053-4", "26253490"]}, {"Citation": "Tang Y., Yi T., Chen H., Zhao Z., Liang Z., Chen H. Quantitative comparison of multiple components in dioscorea nipponica and d. Panthaica by ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Phytochem. Anal. 2013;24:413\u2013422. doi: 10.1002/pca.2428.", "ArticleIdList": ["10.1002/pca.2428", "23508854"]}, {"Citation": "Tang Y.N., Pang Y.X., He X.C., Zhang Y.Z., Zhang J.Y., Zhao Z.Z., Yi T., Chen H.B. UPLC-QTOF-MS identification of metabolites in rat biosamples after oral administration of dioscorea saponins: A comparative study. J. Ethnopharmacol. 2015;165:127\u2013140. doi: 10.1016/j.jep.2015.02.017.", "ArticleIdList": ["10.1016/j.jep.2015.02.017", "25698242"]}, {"Citation": "Ciura J., Szeliga M., Grzesik M., Tyrka M. Next-generation sequencing of representational difference analysis products for identification of genes involved in diosgenin biosynthesis in Fenugreek (Trigonella foenum-graecum) Planta. 2017;245:977\u2013991. doi: 10.1007/s00425-017-2657-0.", "ArticleIdList": ["10.1007/s00425-017-2657-0", "PMC5393294", "28161815"]}, {"Citation": "Vaidya K., Ghosh A., Kumar V., Chaudhary S., Srivastava N., Katudia K., Tiwari T., Chikara S.K. De novo transcriptome sequencing in Trigonella foenum-graecum L. to identify genes involved in the biosynthesis of diosgenin. Plant. Genome. 2013;6:1\u201311. doi: 10.3835/plantgenome2012.08.0021.", "ArticleIdList": ["10.3835/plantgenome2012.08.0021"]}, {"Citation": "Chiang C.T., Way T.D., Tsai S.J., Lin J.K. Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation. FEBS Lett. 2007;581:5735\u20135742. doi: 10.1016/j.febslet.2007.11.021.", "ArticleIdList": ["10.1016/j.febslet.2007.11.021", "18022396"]}, {"Citation": "Li F., Fernandez P.P., Rajendran P., Hui K.M., Sethi G. Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Lett. 2010;292:197\u2013207. doi: 10.1016/j.canlet.2009.12.003.", "ArticleIdList": ["10.1016/j.canlet.2009.12.003", "20053498"]}, {"Citation": "Moalic S., Liagre B., Corbiere C., Bianchi A., Dauca M., Bordji K., Beneytout J.L. A plant steroid, diosgenin, induces apoptosis, cell cycle arrest and cox activity in osteosarcoma cells. FEBS Lett. 2001;506:225\u2013230. doi: 10.1016/S0014-5793(01)02924-6.", "ArticleIdList": ["10.1016/S0014-5793(01)02924-6", "11602250"]}, {"Citation": "Chen P.S., Shih Y.W., Huang H.C., Cheng H.W. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer pc-3 cells by reducing matrix metalloproteinases expression. PLoS ONE. 2011;6:e20164. doi: 10.1371/journal.pone.0020164.", "ArticleIdList": ["10.1371/journal.pone.0020164", "PMC3100339", "21629786"]}, {"Citation": "Raju J., Rao C.V. Diosgenin, a steroid saponin constituent of yams and fenugreek: Emerging evidence for applications. In: Rasooli I., editor. Bioactive Compounds Medicine in Phytomedicine. InTech.; London, UK: 2012. pp. 125\u2013142."}, {"Citation": "Shishodia S., Aggarwal B.B. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression. Oncogene. 2006;25:1463\u20131473. doi: 10.1038/sj.onc.1209194.", "ArticleIdList": ["10.1038/sj.onc.1209194", "16331273"]}, {"Citation": "Das S., Dey K.K., Dey G., Pal I., Majumder A., MaitiChoudhury S., kundu S.C., Mandal M. Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma. PLoS ONE. 2012;7:e46641. doi: 10.1371/journal.pone.0046641.", "ArticleIdList": ["10.1371/journal.pone.0046641", "PMC3471895", "23077516"]}, {"Citation": "Lepage C., Leger D.Y., Bertrand J., Martin F., Beneytout J.L., Liagre B. Diosgenin induces death receptor-5 through activation of p38 pathway and promotes trail-induced apoptosis in colon cancer cells. Cancer Lett. 2011;301:193\u2013202. doi: 10.1016/j.canlet.2010.12.003.", "ArticleIdList": ["10.1016/j.canlet.2010.12.003", "21195543"]}, {"Citation": "Romero-Hernandez L.L., Merino-Montiel P., Montiel-Smith S., Meza-Reyes S., Vega-Baez J.L., Abasolo I., Schwartz S., Jr., Lopez O., Fernandez-Bolanos J.G. Diosgenin-based thio(seleno)ureas and triazolyl glycoconjugates as hybrid drugs. Antioxidant and antiproliferative profile. Eur. J. Med. Chem. 2015;99:67\u201381. doi: 10.1016/j.ejmech.2015.05.018.", "ArticleIdList": ["10.1016/j.ejmech.2015.05.018", "26046314"]}, {"Citation": "Cai B., Liao A., Lee K.K., Ban J.S., Yang H.S., Im Y.J., Chun C. Design, synthesis of methotrexate-diosgenin conjugates and biological evaluation of their effect on methotrexate transport-resistant cells. Steroids. 2016;116:45\u201351. doi: 10.1016/j.steroids.2016.10.006.", "ArticleIdList": ["10.1016/j.steroids.2016.10.006", "27770617"]}, {"Citation": "Jiang S., Fan J., Wang Q., Ju D., Feng M., Li J., Guan Z.B., An D., Wang X., Ye L. Diosgenin induces ros-dependent autophagy and cytotoxicity via mtor signaling pathway in chronic myeloid leukemia cells. Phytomedicine. 2016;23:243\u2013252. doi: 10.1016/j.phymed.2016.01.010.", "ArticleIdList": ["10.1016/j.phymed.2016.01.010", "26969378"]}, {"Citation": "Jagadeesan J., Langeswaran K., Gowthamkumar S., Balasubramanian M.P. Diosgenin exhibits beneficial efficiency on human mammary carcinoma cell line MCF-7 and against N-nitroso-N-methylurea (NMU) induced experimental mammary carcinoma. Biomed. Prev. Nutr. 2013;3:381\u2013388. doi: 10.1016/j.bionut.2013.06.009.", "ArticleIdList": ["10.1016/j.bionut.2013.06.009"]}, {"Citation": "Albini A., Tosetti F., Li V.W., Noonan D.M., Li W.W. Cancer prevention by targeting angiogenesis. Nat. Rev. Clin. Oncol. 2012;9:498\u2013509. doi: 10.1038/nrclinonc.2012.120.", "ArticleIdList": ["10.1038/nrclinonc.2012.120", "22850752"]}, {"Citation": "Folkman J. Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 1971;285:1182\u20131186.", "ArticleIdList": ["4938153"]}, {"Citation": "Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 2002;29:15\u201318. doi: 10.1053/sonc.2002.37263.", "ArticleIdList": ["10.1053/sonc.2002.37263", "12516034"]}, {"Citation": "Folkman J. Angiogenesis: An organizing principle for drug discovery? Nat. Rev. Drug Discov. 2007;6:273\u2013286. doi: 10.1038/nrd2115.", "ArticleIdList": ["10.1038/nrd2115", "17396134"]}, {"Citation": "Selim S., Al Jaouni S. Anti-inflammatory, antioxidant and antiangiogenic activities of diosgenin isolated from traditional medicinal plant, costus speciosus (Koen ex.Retz.) Sm. Nat. Prod. Res. 2016;30:1830\u20131833. doi: 10.1080/14786419.2015.1065493.", "ArticleIdList": ["10.1080/14786419.2015.1065493", "26222585"]}, {"Citation": "He Z., Chen H., Li G., Zhu H., Gao Y., Zhang L., Sun J. Diosgenin inhibits the migration of human breast cancer MDA-MB-231 cells by suppressing VAV2 activity. Phytomedicine. 2014;21:871\u2013876. doi: 10.1016/j.phymed.2014.02.002.", "ArticleIdList": ["10.1016/j.phymed.2014.02.002", "24656238"]}, {"Citation": "Mao Z.J., Tang Q.J., Zhang C.A., Qin Z.F., Pang B., Wei P.K., Liu B., Chou Y.N. Anti-proliferation and anti-invasion effects of diosgenin on gastric cancer BGC-823 cells with HIF-1alpha shrnas. Int. J. Mol. Sci. 2012;13:6521\u20136533. doi: 10.3390/ijms13056521.", "ArticleIdList": ["10.3390/ijms13056521", "PMC3382793", "22754381"]}, {"Citation": "Srinivasan S., Koduru S., Kumar R., Venguswamy G., Kyprianou N., Damodaran C. Diosgenin targets AKT-mediated prosurvival signaling in human breast cancer cells. Int. J. Cancer. 2009;125:961\u2013967. doi: 10.1002/ijc.24419.", "ArticleIdList": ["10.1002/ijc.24419", "19384950"]}, {"Citation": "Sowmyalakshmi S., Ranga R., Gairola C.G., Chendil D. Effect of diosgenin (Fenugreek) on breast cancer cells. Proc. Am. Assoc. Cancer Res. 2005;46:1382."}, {"Citation": "Corbiere C., Liagre B., Bianchi A., Bordji K., Dauca M., Netter P., Beneytout J.L. Different contribution of apoptosis to the antiproliferative effects of diosgenin and other plant steroids, hecogenin and tigogenin, on human 1547 osteosarcoma cells. Int. J. Oncol. 2003;22:899\u2013905. doi: 10.3892/ijo.22.4.899.", "ArticleIdList": ["10.3892/ijo.22.4.899", "12632085"]}, {"Citation": "Liagre B., Bertrand J., Leger D.Y., Beneytout J.L. Diosgenin, a plant steroid, induces apoptosis in COX-2 deficient K562 cells with activation of the p38 map kinase signalling and inhibition of NF-kappaB binding. Int. J. Mol. Med. 2005;16:1095\u20131101. doi: 10.3892/ijmm.16.6.1095.", "ArticleIdList": ["10.3892/ijmm.16.6.1095", "16273292"]}, {"Citation": "Leger D.Y., Liagre B., Corbiere C., Cook-Moreau J., Beneytout J.L. Diosgenin induces cell cycle arrest and apoptosis in hel cells with increase in intracellular calcium level, activation of CPLA2 and COX-2 overexpression. Int. J. Oncol. 2004;25:555\u2013562. doi: 10.3892/ijo.25.3.555.", "ArticleIdList": ["10.3892/ijo.25.3.555", "15289856"]}, {"Citation": "Corbiere C., Liagre B., Terro F., Beneytout J.L. Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells. Cell. Res. 2004;14:188\u2013196. doi: 10.1038/sj.cr.7290219.", "ArticleIdList": ["10.1038/sj.cr.7290219", "15225412"]}, {"Citation": "Wang S.L., Cai B., Cui C.B., Liu H.W., Wu C.F., Yao X.S. Diosgenin-3-O-alpha-l-rhamnopyranosyl-(1\u21924)-beta-d-glucopyranoside obtained as a new anticancer agent from dioscorea futschauensis induces apoptosis on human colon carcinoma HCT-15 cells via mitochondria-controlled apoptotic pathway. J. Asian Nat. Prod. Res. 2004;6:115\u2013125. doi: 10.1080/1028602031000147357.", "ArticleIdList": ["10.1080/1028602031000147357", "15008458"]}, {"Citation": "Raju J., Patlolla J.M., Swamy M.V., Rao C.V. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiol. Biomarkers Prev. 2004;13:1392\u20131398.", "ArticleIdList": ["15298963"]}, {"Citation": "Malisetty V.S., Patlolla J.M.R., Raju J., Marcus L.A., Choi C.L., Rao C.V. Chemoprevention of colon cancer by diosgenin, a steroidal saponin constituent of fenugreek. Proc. Am. Assoc. Cancer Res. 2005;46:2473."}, {"Citation": "Miyoshi N., Nagasawa T., Mabuchi R., Yasui Y., Wakabayashi K., Tanaka T., Ohshima H. Chemoprevention of azoxymethane/dextran sodium sulfate-induced mouse colon carcinogenesis by freeze-dried yam sanyaku and its constituent diosgenin. Cancer Prev. Res. (Phila.) 2011;4:924\u2013934. doi: 10.1158/1940-6207.CAPR-10-0279.", "ArticleIdList": ["10.1158/1940-6207.CAPR-10-0279", "21367960"]}, {"Citation": "Yan L.L., Zhang Y.J., Gao W.Y., Man S.L., Wang Y. In vitro and in vivo anticancer activity of steroid saponins of paris polyphylla var. Yunnanensis. Exp. Oncol. 2009;31:27\u201332.", "ArticleIdList": ["19300413"]}, {"Citation": "Marker R.E., Sterols C.V. The preparation of testosterone and related compounds from sarsasapogenin and diosgenin. J. Am. Chem. Soc. 1940;62:2543\u20132547. doi: 10.1021/ja01866a077.", "ArticleIdList": ["10.1021/ja01866a077"]}, {"Citation": "Tietze L.F., Bell H.P., Chandrasekhar S. Natural product hybrids as new leads for drug discovery. Angew. Chem. Int. Ed. 2003;42:3996\u20134028. doi: 10.1002/anie.200200553.", "ArticleIdList": ["10.1002/anie.200200553", "12973759"]}, {"Citation": "Sanchez-Sanchez L., Hernandez-Linares M.G., Escobar M.L., Lopez-Munoz H., Zenteno E., Fernandez-Herrera M.A., Guerrero-Luna G., Carrasco-Carballo A., Sandoval-Ramirez J. Antiproliferative, cytotoxic, and apoptotic activity of steroidal oximes in cervicouterine cell lines. Molecules. 2016;21:1533. doi: 10.3390/molecules21111533.", "ArticleIdList": ["10.3390/molecules21111533", "PMC6273349", "27854258"]}, {"Citation": "Masood Ur R., Mohammad Y., Fazili K.M., Bhat K.A., Ara T. Synthesis and biological evaluation of novel 3-O-tethered triazoles of diosgenin as potent antiproliferative agents. Steroids. 2017;118:1\u20138. doi: 10.1016/j.steroids.2016.11.003.", "ArticleIdList": ["10.1016/j.steroids.2016.11.003", "27864018"]}, {"Citation": "Liu C., Xie F., Zhao G.D., Wang D.F., Lou H.X., Liu Z.P. Synthetic studies towards 1alpha-hydroxysolasodine from diosgenin and the unexpected tetrahydrofuran ring opening in the birch reduction process. Steroids. 2015;104:214\u2013219. doi: 10.1016/j.steroids.2015.10.006.", "ArticleIdList": ["10.1016/j.steroids.2015.10.006", "26476186"]}, {"Citation": "Hamid A.A., Kaushal T., Ashraf R., Singh A., Chand Gupta A., Prakash O., Sarkar J., Chanda D., Bawankule D.U., Khan F., et al. (22beta,25R)-3beta-hydroxy-spirost-5-en-7-iminoxy-heptanoic acid exhibits anti-prostate cancer activity through caspase pathway. Steroids. 2017;119:43\u201352. doi: 10.1016/j.steroids.2017.01.001.", "ArticleIdList": ["10.1016/j.steroids.2017.01.001", "28143704"]}, {"Citation": "Ghosh S., More P., Derle A., Kitture R., Kale T., Gorain M., Avasthi A., Markad P., Kundu G.C., Kale S., et al. Diosgenin functionalized iron oxide nanoparticles as novel nanomaterial against breast cancer. J. Nanosci. Nanotechnol. 2015;15:9464\u20139472. doi: 10.1166/jnn.2015.11704.", "ArticleIdList": ["10.1166/jnn.2015.11704", "26682367"]}]}], "History": [{"Year": "2018", "Month": "3", "Day": "17"}, {"Year": "2018", "Month": "5", "Day": "4"}, {"Year": "2018", "Month": "5", "Day": "16"}, {"Year": "2018", "Month": "5", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["29783752", "PMC5986524", "10.3390/nu10050645", "nu10050645"]}}]}